Your browser doesn't support javascript.
loading
Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy.
Vyas, Avani; Gomez-Casal, Roberto; Cruz-Rangel, Silvia; Villanueva, Hugo; Sikora, Andrew G; Rajagopalan, Pavithra; Basu, Devraj; Pacheco, Jonathan; Hammond, Gerald R V; Kiselyov, Kirill; Duvvuri, Umamaheswar.
Affiliation
  • Vyas A; Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213.
  • Gomez-Casal R; UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA 15232.
  • Cruz-Rangel S; Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213.
  • Villanueva H; Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213.
  • Sikora AG; UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA 15232.
  • Rajagopalan P; Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, TX 77030.
  • Basu D; Department of Head and Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Pacheco J; Department of Otorhinolaryngology, University of Pennsylvania, Philadelphia, PA 19104.
  • Hammond GRV; Department of Otorhinolaryngology, University of Pennsylvania, Philadelphia, PA 19104.
  • Kiselyov K; Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA 15260.
  • Duvvuri U; Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA 15260.
Proc Natl Acad Sci U S A ; 119(12): e2100670119, 2022 03 22.
Article in En | MEDLINE | ID: mdl-35286200

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cisplatin / Anoctamin-1 / Head and Neck Neoplasms / Neoplasm Proteins / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cisplatin / Anoctamin-1 / Head and Neck Neoplasms / Neoplasm Proteins / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2022 Document type: Article